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of glutamate and GABA (Ward et al., 1983; Battaglioli and Martin, 
1990; Sonnewald et al., 1993) in order to maintain increased neuro-
nal activity (Szerb and O’Regan, 1985; Storm-Mathisen et al., 1986; 
Verderio et al., 1999; Holten and Gundersen, 2008). Furthermore, 
glutamine synthetase, the key enzyme catalyzing the formation of 
glutamine from glutamate, is localized to perisynaptic astroglial 
processes (Martínez-Hernandez et al., 1977), whereas phosphate-
activated glutaminase (PAG) catalyzing regeneration of glutamate 
from glutamine is enriched in nerve terminals (Kvamme, 1983; 
Laake et al., 1999). However, the molecular mechanisms involved 
in glutamine transport into neurons remain to be elucidated.
The glutamate/GABA-glutamine cycle theory has been bolstered 
by the identifi cation of the fi rst system N transporter (SN1) and 
by the identifi cation of a novel family of neutral amino acid tran-
sporters (SLC38) with a preference for glutamine (Chaudhry et al., 
1999, 2002a). SN1 is specifi cally targeted to perisynaptic astroglial 
processes and mediates glutamine release at normal physiological 
conditions (Chaudhry et al., 2001; Boulland et al., 2002). Recently, 
a role for the homologous system A transporter SAT2 (aternati-
vely termed SA1, SNAT2, ATA2) has been demonstrated in neu-
rotransmitter generation (Jenstad et al., 2009): SAT2 is targeted to 
the somatodendritic segments of glutamatergic neurons where it 
also participates in sustaining retrograde signaling by glutamate. 
SAT2 localization complements that of SN1 and suggests concerted 
action of these transporters in glutamine shuttling from astroglial 
cells to neurons. The localization of these transporters contributes 
to our better understanding of the molecular architecture of this 
essential metabolic circuitry. However, the lack or restricted SAT2 
expression in GABAergic neurons calls for signifi cant contributions 
from other transporters (Jenstad et al., 2009).
INTRODUCTION
Classical neurotransmission involves quantal release of a neuro-
transmitter captured in synaptic vesicles from presynaptic spe-
cializations and subsequent neurotransmitter action at specifi c 
postsynaptic receptors. Some neurotransmitters (monoamines 
and acetylcholine) or their metabolites undergo presynaptic reup-
take not only in order to terminate their action but also to recycle 
released molecules. A substantial amount of released glutamate 
and GABA, the major fast transmitters, is instead translocated into 
perisynaptic astroglial processes (Schousboe, 2000; Danbolt, 2001; 
Fan et al., 2006). Thus, there is a net loss of neuronal glutamate and 
GABA at active synapses while their levels coincidently increase in 
perisynaptic astroglial cells. Given the prevalence of glutamater-
gic and GABAergic synapses and their contribution to generating 
complex neuronal network discharge patterns, maintaining the rate 
of signaling at these synapses requires continuous replenishment 
of the releasable neurotransmitter pool. Although glutamate and 
GABA actions were in the forefront of decade-long research due 
to their roles in (patho-)physiological brain functions, surprisin-
gly little is known about the molecular mechanisms that main-
tain their metabolic balance, in particular their targeting towards 
synaptic release.
According to the prevailing hypothesis, glutamine is the major 
amino acid precursor for both glutamate and GABA synthesis, 
participating in a glutamate/GABA-glutamine cycle during which 
released glutamate and GABA are translocated into astroglial cells, 
converted into glutamine, and subsequently shuttled back to neu-
rons to regenerate these neurotransmitters (Chaudhry et al., 2002a; 
Albrecht et al., 2007). This mechanistic view is supported by glu-
tamine being preferentially metabolized to the transmitter pools 
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SAT1 (alternatively termed GlnT, SA2, SNAT1 and ATA1) is another 
member of the SLC38 family with preferential affi nity for glutamine 
(Sugawara et al., 2000; Varoqui et al., 2000; Chaudhry et al., 2002b). 
In situ hybridization reveals high SAT1 transcript levels in GABAergic 
neurons (Chaudhry et al., 2002a). Therefore, we have investigated 
anatomical indices of SAT1’s involvement in GABA formation. We 
have generated highly selective SAT1 antibodies to demonstrate that 
SAT1 is predominantly expressed in GABAergic neurons in many 
brain regions. SAT1 immunostaining in GABAergic neurons was 
confi rmed using mice carrying green fl uorescence protein (GFP) 
knocked into the GAD67 locus (GADgfp/+), the key enzyme involved 
in GABA formation. At the cellular level, SAT1 is mainly targeted to 
the plasma membrane, but the presence of additional intracellular 
immunolabeling colocalized with syntaxin-6 suggests intracellular 
reservoirs and regulated SAT1 traffi cking. Cumulatively, our data 
identify SAT1 as a molecular entity whose function can be imperative 
for sustaining glutamine uptake and GABA generation during high 
fi ring frequencies in inhibitory neurons.
MATERIALS AND METHODS
MATERIALS
3,3′-diaminobenzidine (DAB), 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI), bovine serum albumin (BSA), fetal calf 
serum (FCS), sodium ethylenediamine tetraacetate (EDTA), poly-
d-lysine, nerve growth factor (NGF), ECM gel, phenylmethanesul-
fonyl fl uoride (PMSF), Trizma base, Trizma HCl, ethanolamine, 
hydrogen peroxide, porcine gelatine, saponin, Wisteria fl oribunda 
lectin (WFA), goat anti-rabbit (GAR) IgG (H + L) F(ab)
2
-FITC, 
goat anti-goat (GAG) IgG (H + L) F(ab)
2
-Cy3, GAR-Cy5, mouse 
anti-FLAG were from Sigma-Aldrich, Norway. Biotinylated donkey 
anti-rabbit, streptavidin-biotinylated horseradish peroxidase com-
plex, pGEX-3X expression vector, Sepharose 4B column were pur-
chased from GE Healthcare. Alkaline phosphatase substrate buffer, 
DNAse, ammonium persulfate, isopropyl-β-d- thiogalactopyranosid 
(IPTG), TEMED were from Promega. Newborn calf serum (NCS), 
normal goat serum (NGS), Alexa-488, Alexa-555, Lipofectamine 
2000, glutamine, pcDNA3.1, penicillin, streptomycin, trypsin, 
DMEM-GlutaMAX, OptiMEM were provided by Invitrogen. 
Fluoromount G: Electron Microscopy Sciences (EMS), USA. 
Nitrocellulose sheets (0.22 µm), electrophoresis equipment: 
Hoefer Scientifi c Instruments, USA. Sodium dodecyl sulfate (SDS): 
Pierce, USA. pCMV-Tag1: Stratagene, Norway. Glycerol gelatine: 
Chemi-Teknik, Norway. Anti-parvalbumin: Swant, Switzerland. 
Paraformaldehyde (PFA): TAAB, UK. Affi gel-15, Criterion gels: 
Bio-Rad, Norway. Sheep anti-rabbit IgG, particle concentrator: 
Dynal Biotech., Norway. PC12 cells were obtained from European 
Collection of Cell Cultures (ECACC), UK. Matrigel, anti-synta-
xin-6: BD Biosciences, USA. Normal donkey serum, carbocyanine 
3 (Cy3)-conjugated secondary antibodies raised in donkey: Jackson 
ImmunoResearch, PA, USA. Anti-synaptophysin: Abcam, Norway. 
Zeiss Axioplan 2, AxioVision Rel 4.4, LSM 5 META confocal laser-
scanning microscope: Zeiss, Germany.
ANIMALS AND ETHICAL APPROVAL OF STUDIES
Ten Wistar rats (180–200 g) were purchased from B & K Universal 
(Sweden) and used for western blotting and immunocytochemi-
stry. The animals were kept and handled according to European 
regulations and under veterinary agreement and supervision at the 
animal facility of the Institute of Basic Medical Sciences, University 
of Oslo. Sprague-Dawley rats for interneuron isolation and mul-
tiple labeling experiments were kept according to the European 
Communities Council Directive (86/609/EEC) and their use 
was approved by Stockholms Norra Djurförsöksetiska Nämnd 
(N26/2005 and N38/2005).
PRIMARY ANTIBODIES AGAINST SAT1
System N and system A transporters show high degree of amino 
acid sequence homology. However, they all have a long intracellu-
lar N-terminus exhibiting substantial degree of amino acid diver-
sity (Chaudhry et al., 2002b). Computer predictions showed that 
the composition of amino acids in the N-terminus of SAT1 was 
highly antigenic (data not shown). We have therefore generated a 
glutathione S-transferase (GST) fusion protein containing SAT1’s 
N- terminus by subcloning corresponding nucleotides into a pGEX-
3X vector in frame with a preceding GST. Expression of the fusion 
protein was induced in Escherichia coli by IPTG followed by puri-
fi cation of the fusion protein on a Sepharose 4B column (Boulland 
et al., 2002). The GST-SAT1-N-terminal fusion protein was mixed 
with Freund’s adjuvant (complete the fi rst time and incomplete 
the subsequent times) and injected subcutaneously into rabbits. 
Antibodies against GST were removed by purifying the ensuing 
sera on a column containing affi gel-15 coupled to GST. The fl ow-
through was subsequently run on an affi gel-15 column containing 
immobilized GST-SAT1-N-terminus. Affi nity-purifi ed antibodies 
were eluted from the column by rapidly decreasing the pH and then 
collected as described elsewhere (Boulland et al., 2002).
PREPARATION OF PROTEIN EXTRACTS FROM RAT BRAIN 
AND CULTURED CELLS
Animals were sacrifi ced by stunning and decapitation. Brains were 
rapidly dissected out and snap-frozen in liquid nitrogen and sto-
red at −80oC until further processing. Prior to Western blotting, 
tissues were thawed and homogenized in SDS solubilization buffer 
[10 mg/ml SDS, 1 mM PMSF, 5 mM EDTA and 10 mM sodium 
phosphate buffer (NaPi)]. The protein concentration was measured 
by Lowry’s assay using BSA as standard (Boulland et al., 2004). 
Brain extracts were mixed with SDS-sample buffer (10% glycerol, 
62.5 mM Tris-HCl, pH 6.8, 2% SDS, 0.01 mg/ml bromphenol blue) 
prior to electrophoretic separation.
COS cells were grown in 24 well plates in DME medium con-
taining 10% calf serum and 1× pencillin/streptomycin. pcDNA3.1 
vector either empty or containing sequences of SAT1 or SAT2 were 
transfected into COS cells by electroporation. After 3–4 days, tran-
sfected and untransfected COS cells were harvested by trypsin, 
solubilized in SDS solubilization buffer, their protein concentration 
measured, and their extracts solubilized in SDS-sample buffer as 
described above.
ELECTROPHORESIS AND IMMUNOBLOTTING
SDS-PAGE was performed as described (Boulland et al., 2002). 
Thirty micrograms of homogenates were loaded per lane, and run 
at 10 V for 90 min. After separation, proteins were electroblotted 
(100 V, 2 h) onto nitrocellulose membranes. These were blocked 
with 1% (v/w) porcine gelatine in phosphate buffered saline (PBS: 
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140 mM NaCl, 2.7 mM KCl, 1.5 mM KH
2
PO
4
 and 8.1 mM Na
2
HPO
4
, 
pH 7.4), and incubated overnight with SAT1 antibodies (0.3–1.0 µg/
ml) in the same blocking solution. The blots were rinsed in PBS, 
reblocked in the blocking solution and incubated with alkaline pho-
sphatase-conjugated secondary antibodies diluted in blocking solu-
tion. After extensive rinsing, membranes were immersed in alkaline 
phosphatase substrate buffer and the immunoreaction was allowed 
to develop. Finally, nitrocellulose membranes were rinsed with water 
and dried at room temperature.
PERFUSION FIXATION AND IMMUNOPEROXIDASE IMMUNOSTAINING
Animals were perfusion fi xed and parasagittal sections were immu-
noperoxidase-stained as described (Chaudhry et al., 1998). Briefl y, 
the animals were deeply anaesthetized by Equithesin at 2.5 ml/kg 
rat, and fi xed by transcardial perfusion with 4% PFA and 0.05% GA 
in PBS. Brains were subsequently dissected out and postfi xed over-
night in the same fi xative. Free-fl oating sections (40 µm thick) were 
made by a microtome with a vibrating blade (Leica) and treated 
with 1 M ethanolamine-HCl (pH 7.4) and 1% H
2
O
2
. Non-specifi c 
labeling was blocked by incubation with 10% NCS followed by 
incubation of the sections with primary antibodies (3–10 µg/ml) 
overnight at room temperature in a blocking solution containing 
3% NCS (with or without Triton X-100). Following extensive rin-
sing in PBS, the sections were preincubated again in a blocking 
solution containing 3% NCS and subsequently incubated with 
biotin-coupled secondary antibodies. The immunoreaction was 
developed with the biotin-streptavidin-peroxidase system and DAB 
activated by 0.1% H
2
O
2
.
IMMUNOFLUORESCENCE STAINING OF DIFFERENTIATED PC12 CELLS
PC12 cells were transfected with FLAG-tagged SAT1 in a pCMV-
Tag1 vector, using Lipofectamine 2000. Transfected cells were grown 
for 3 days in the presence of NGF (50–100 ng/ml) on glass coverslips 
coated with poly-d-lysine (0.1 mg/ml) and ECM gel (1–1.5 µg/ml). 
Subsequently, cells were immersion fi xed for 30 min in 4% PFA in 
NaPi (pH 7.4), and then treated with 1 M ethanolamine for 10 min. 
Preincubation with a blocking solution (10% NGS, 3% BSA, 0.1% 
saponin in TBS pH 7.4) was followed by 2–4 h incubation with 
primary antibodies [anti-SAT1 (1 µg/ml), anti-FLAG (1:1000), 
anti-syntaxin-6 (1:200) and anti-synaptophysin 1:200)] in the same 
blocking solution. After extensive rinsing in PBS, immunoreactivity 
was revealed by fl uorochromated secondary antibodies [Alexa-488 
(1:1000) and Alexa-555 (1:1000)], rinsed in PBS, and mounted on 
glass slides using Flouromount.
SAT1 LOCALIZATION IN GAD67GFP/+ MICE AND CULTURED 
INTERNEURONS
Mice heterozygously expressing GFP knocked into the GAD67 
locus (GAD67gfp/+) (Tamamaki et al., 2003) were perfusion fi xed 
(see above). Interneurons were isolated from fetal cortices of 
E18/19 Sprague-Dawley rat embryos. Cortices were enzymatically 
dissociated and interneurons were sorted immuno-magnetically as 
described (Berghuis et al., 2004). Immunofl uorescence localization 
of SAT1 was performed according to published procedures both on 
forebrain sections and in cultured neurons (Berghuis et al., 2004). 
Cells were fi xed in 4% PFA in NaPi buffer (0.1 M, pH 7.4; PB) for 
20 min, rinsed in PB, and permeabilized with 0.25% Triton X-100 
for 15 min. Blocking of aspecifi c labeling was achieved by applying 
5% normal donkey serum and 2% BSA in PB for 1 h. Subsequently, 
the specimens were exposed to affi nity-purifi ed rabbit anti-SAT1 
(1:1000), anti-PARV (1:2000) and WFA (20 µg/ml) in 0.1 M PB 
at 4oC overnight. Immunoreactivities were visualized with appro-
priate cocktails of secondary antibodies raised in donkey (1:200). 
Pre-absorption of the primary antibody with the corresponding 
fusion protein (20 µg/ml) in control experiments led to a complete 
absence of immunolabeling.
RESULTS
NOVEL SAT1 ANTIBODIES ARE HIGHLY SELECTIVE
To assess the (sub-)cellular localization of SAT1, we raised anti-
bodies in two rabbits against its N-terminal, the most unique 
and antigenic region. The specifi city of antisera we have obtained 
is supported by selective immunostaining of electrophoretically 
separated extracts of COS cells transiently expressing SAT1, but 
not of cells transiently transfected with SAT2 or a mock vector 
(Figure 1A). The smear seen on blots suggests high production 
of heterologous SAT1 by COS cells, as has been demonstrated for 
SAT2, SN1 and other transporter proteins overexpressed in this 
cell line (Peter et al., 1995; Boulland et al., 2002; Jenstad et al., 
2009). The highest possible specifi city of our antibodies was fur-
ther ensured by double purifi cation: sera were affi nity-purifi ed 
through an agarose column containing immobilized GST followed 
by an agarose column containing immobilized fusion proteins 
of GST and SAT1-N-terminal (see Methods). Immunoblots of 
electrophoretically separated total brain extracts incubated with 
affi nity-purifi ed antibodies reveal a broad diffuse heterogeneous 
band at about 50 kDa (Figure 1B). This is in agreement with 
the SAT1 protein’s predicted molecular weight (53 kDa) of 485 
amino acids (Chaudhry et al., 2002b). Moreover, this band resem-
bles in appearance the bands obtained by Western blotting of rat 
brain extracts by affi nity-purifi ed antibodies against two homo-
logous transporters (SN1 and SAT2) as well as other transporters 
(Dehnes et al., 1998; Boulland et al., 2002; Jenstad et al., 2009). No 
additional bands were seen by anti-SAT1-N1, while two additio-
nal slender bands of heavier molecular weight were detected by 
anti-SAT1-N2. To minimize bias and false-positive outcome in 
subsequent experiments, only data obtained with the anti-SAT1-
N1 antibody was accepted and presented in this report, unless 
specifi cally stated otherwise.
We further validated the SAT1-N1 antibody’s specifi city by 
immunocytochemistry: PC12 neuroblastoma cells were transien-
tly transfected with SAT1 containing a FLAG-tag after the initial 
methionine and differentiated to attain neuron-like characteristics 
with NGF. Double labeling of these cells with the affi nity-purifi ed 
SAT1-N1 antibody and a commercial antibody against FLAG-tag 
using different fl uorochrome conjugated secondary antibodies, 
showed localization of both immunoreactions in the same subset 
of cells and demonstrated that the protein is distributed throu-
ghout these cells, including their processes (Figure 1C). Finally, 
immunoperoxidase staining of parasagittal brain sections reveals 
similar and highly cell-specifi c immunostaining for SAT1 by both 
antibodies (Figure 2A shows data for anti-SAT1-N1). Except for 
a weak staining in the molecular layer of the cerebellar cortex and 
layer I of the piriform cortex, no immunostaining remained upon 
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preincubation of the antibodies with the GST fusion protein used 
to immunize rabbits (Figure 2B). Consequently, this staining was 
disregarded as it could be attributed to non-specifi c contribution of 
Ig-immunostaining as reported earlier (Yoshimi et al., 2002). Thus, 
except for these two subregions, the affi nity-purifi ed anti-SAT1-N1 
antibody has passed our specifi city criteria and was accepted to 
selectively recognize SAT1.
SAT1 DISTRIBUTION RESEMBLES THAT OF GAD67 IN THE BRAIN
To evaluate whether SAT1 may have cell type-specifi c func-
tions in glutamine uptake and metabolism we investigated its 
cellular localization and compared its distribution with select 
 neurotransmitter-specifi c markers. Survey of the parasagittal brain 
showed regional variations in SAT1 expression with highest levels 
of immunoreactivity in brainstem and cerebellum (Figure 2A). 
Thalamus, hypothalamus, the superior and inferior colliculi as well 
as the nucleus of the lateral lemniscus were prominently immu-
nostained for SAT1 (Figure 2A). These regions harbor a large 
number of GABAergic neurons, i.e., cells containing GABA, its 
synthesizing enzyme glutamic acid decarboxylase (GAD) and/or 
the GABAergic neuron-specifi c Ca2 + -binding protein parvalbu-
min (PARV) (Ottersen and Storm-Mathisen, 1984; Mugnaini and 
Oertel, 1985; Appell and Behan, 1990; De et al., 1994). In contrast, 
regions rich in glutamatergic neurons, such as the cerebral cor-
tex and the hippocampus (Ottersen and Storm-Mathisen, 1984, 
1986), had much lower overall levels of SAT1 immunoreactivity 
(Figure 2A).
Subregional and cellular distribution of SAT1 expression was 
investigated by high resolution light and confocal laser-scanning 
microscopy. Furthermore, we explored whether SAT1 is preferen-
tially associated to inhibitory neurons being genetically tagged in 
GAD67gfp/+ reporter mice (Tamamaki et al., 2003). The most pro-
nounced immunostaining for SAT1 is concentrated in neurons of 
the reticular thalamic nucleus (Figures 2C,D). SAT1 co-exists with 
PARV and gfp in GAD67gfp/+ mice (Figures 6B,C) confi rming that 
SAT1-positive neurons are GABAergic.
The ventral thalamic nucleus zona incerta, which is contiguous 
to the thalamic reticular nucleus, is rich in GAD and GABA-contai-
ning neurons that innervate thalamic nuclei (Mugnaini and Oertel, 
1985; Benson et al., 1992; Bartho et al., 2002). The cells of zona 
incerta are also enriched in SAT1 (Figure 2A). In contrast, SAT1 
immunolabeling is weaker in cells scattered across the adjacent ven-
FIGURE 1 | Characterization of antibodies raised against SAT1. (A) Two rabbits 
were immunized with a GST fusion protein containing the N-terminus of SAT1. The 
sera obtained were tested for specifi city by immunoblotting on extracts from COS 
cells transiently transfected with SAT1 (1), SAT2 (2) or a mock vector (3). Both 
antibodies revealed an immunoreaction restricted to extracts from SAT1 
transfected cells (results shown only for anti-SAT1-N1). (B) The SAT1 selective sera 
were affi nity purifi ed and tested on rat brain extracts separated by SDS-PAGE. A 
broad band close to 50 kDa was obtained by both antibodies (1 and 2). Two 
additional slender bands of higher molecular weight were detected by anti-SAT1-
N2 antibody (2). (C) Differentiated PC12 cells transiently transfected with FLAG-
tagged SAT1 were double stained with SAT1-N1 antibody (C’) and a commercial 
antibody against FLAG-epitope (C’’). Superimposition of the images shows that 
both antibodies stain the same subset of PC12 cells. Note that the staining occurs 
in the cell bodies as well as in their processes. Note also that a cell not 
immunostained by anti-FLAG is not immunostained for SAT1 either. (D) SAT1 
(green; D’) is targeted to the processes also labeled for synaptophysin (red; D’’), a 
vesicular protein, demarcating axonal endings of differentiated SAT1 transfected 
PC12 cells. Note that an adjacent putative untransfeced cell stains strongly for 
synaptophysin, but eludes immunostaining by SAT1 antibody. (E) Double labeling 
of differentiated SAT1 transfected PC12 for SAT1 and syntaxin-6 (stx6), a marker of 
the trans-Golgi network, shows pronounced colocalization in the perinuclear 
region. All sections have been counterstained by DAPI (blue). Scale bar: 20 µm.
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FIGURE 2 | See complete caption next page.
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tral posteromedial thalamic nucleus (Figures 2C,D) which do not 
immunostain for GAD either (Mugnaini and Oertel, 1985). Finally, 
barely, if any, SAT1  immunostaining was detected in the internal 
capsule (Figures 2B,C). This differential immunostaining of the 
thalamus and adjacent  territories disappears upon preincubation 
of the affi nity-purifi ed SAT1 antibodies with their corresponding 
immunizing GST-SAT1 fusion protein (Figure 2B) reinforcing 
selective SAT1 immunostaining.
Relay neurons of the pontine nucleus participate in the corti-
copontocerebellar pathway, which constitutes a major excitatory 
input to the cerebellum (Beitz et al., 1986). The pontine nucleus 
itself receives extrinsic inhibitory afferents making a dense plexus 
of GABAergic processes and a minor number of cell bodies that 
also immunostain for GABA and GAD (Border and Mihailoff, 
1985; Brodal et al., 1988; Feldblum et al., 1993). SAT1 expression 
is strong in the pontine nucleus and reveals the dense plexus 
of GABAergic processes in addition to cell bodies (Figure 2E). 
Moderate SAT1 immunoreactivity is detected in the facial nucleus 
(Figure 2E), another nucleus with GABAergic input from seve-
ral brain stem regions. The GABAergic projections to the facial 
nucleus originate among other areas in the reticular formation 
(Vaughan, 1994; Li et al., 1997) and accordingly the pons and 
medulla oblongata harbor scattered neurons strongly immuno-
stained for SAT1 (Figures 2E,F). Note that SAT1 immunostaining 
is enriched in the cell bodies as well as processes of these neurons 
(Figures 2E,F; insets). Finally, whilst principal motoneurons of the 
facial nucleus are primarily cholinergic in the adult rat (Yew et al., 
1996), robust GAD67 expression is detected in the principal neu-
rons of lateral superior olive (LSO) (Jenkins and Simmons, 2006). 
Accordingly, we fi nd stronger immunostaining of LSO compared 
to facial nucleus (Figure 2E).
The cells in the nucleus of the lateral olfactory tract are strongly 
immunostained for SAT1 both in their cell bodies and their proces-
ses (Figure 2G). In the spinal cord, SAT1 immunoreactivity is exclu-
ded from the white matter. However, the entire grey matter (anterior 
and posterior horn and grey commissure) contains scattered cell 
bodies moderately immunostained for SAT1 (Figure 2H).
In summary, SAT1 immunoreactivity is restricted to the grey 
matter, and is enriched in a subset of neurons e.g. in the reticu-
lar formation and a number of nuclei in the brain stem. SAT1 
 immunoreactivity – in general – is most pronounced in GAD+ 
neurons with well-known GABAergic activity.
SAT1 IS ASSOCIATED WITH GABAergic NEURONS
To precisely evaluate SAT1 expression in GABAergic cells, we 
investigated broadly studied GABAergic neuron populations. 
In the cerebellum, SAT1 immunoreactivity occurs in Purkinje 
cells, the principal projection neurons (Chaudhry et al., 1998) 
but is undetectable in Bergmann glia ensheathing Purkinje cells 
(Figure 2I, lower inset). However, the strongest immunostaining 
for SAT1 in the cerebellum occurs in some scattered large somata 
cells in the granule cell layer (Figure 2I, upper inset) – an appea-
rance and distribution consistent with Golgi cells – local GAD+ 
GABAergic interneurons exerting inhibitory effects on granule 
cells (Nusser et al., 1998; Takayama and Inoue, 2004). Despite 
a larger number of the cerebellar granule cells, SAT1 immuno-
reactivity is weak in the remaining layer (Figure 2I, upper inset). 
Finally, the cerebellar white matter shows insignifi cant immu-
nostaining for SAT1. This corresponds with low signal intensity 
in the internal capsule (Figures 2C,D) and the white matter in 
the spinal cord (Figure 2H). SAT1’s association with GABAergic 
neurons is also supported by immunostaining of the dorsal coch-
lear nucleus (Figure 2A) where cartwheel neurons share many of 
the characteristics of cerebellar Purkinje cells (Mugnaini et al., 
1987), including the expression of not only GAD but also SAT1 
(data not shown).
 The globus pallidus and substantia nigra of the basal ganglia – a 
major cerebral system involved in regulation of motor coordination 
and control – contain the highest levels of GABA in the CNS (Fahn 
and Cote, 1968; Okada et al., 1971; Schmued et al., 1989). Some of 
the most pronounced cellular SAT1 expression is found in output 
cells of the globus pallidus (Figure 3A). High power microscopy 
reveals strong SAT1 immunoreactivity on the plasma membranes of 
their processes leaving their cytosol largely unstained (Figure 3B). 
FIGURE 2 | Prominent immunoperoxidase staining for SAT1 in a subset of 
neurons in several brain regions. (A) Immuneperoxidase staining of free-fl oating 
parasagittal brain sections reveals SAT1 localization in many subregions. The 
highest staining intensity is found in thalamus, mesencephalic region and 
cerebellum, while cortex, hippocampus and striatum over all have comparatively 
lower levels of staining. (B) The strong SAT1-like immunoreactivity is abolished 
when the antibodies are preincubated with the GST fusion protein used to 
immunize rabbits (result shown for anti-SAT1-N1). (C,D) Prominent cellular SAT1 
immunoreactivity is detected in the reticular thalamic nucleus (Rt) by both 
antibodies (anti-SAT1-N1 and anti-SAT1-N2, in C and D, respectively). The ventral 
posterolateral thalamic nucleus (VPL) also contains scattered SAT1 
immunoreactive cells although less intensely stained. Very few SAT1 
immunolabeled cells are detected in the internal capsule (ic). (E) In the brain stem, 
SAT1 immunoreactivity is enriched in the pontine nucleus (Pn). SAT1 
immunostained cells are also detected in the lateral superior olive (LSO) and facial 
nucleus (7n). Strongly immunostained neuron-like cells appear in the oral part of 
the pontine reticular nucleus (PnO) in which SAT1 immunoreactivity is distributed 
in the cell body as well as their processes (inset). (F) The medulla oblongata 
harbors scattered neurons in the reticular formation strongly immunostained for 
SAT1. The inset shows some neuron-like cells enriched with strong SAT1 
immunostaining distributed throughout their entire cellular extension including 
their processes. (G) Prominent SAT1 immunolabeling is detected in neuron-like 
cells in the lateral olfactory tract nucleus. (H) In the spinal cord, moderate to strong 
SAT1 immunostaining is detected in neuron-like cells in the grey matter (Gm). No 
immunostained cell bodies are detected in the spinal white matter (W). (I) In the 
cerebellar granule cell layer (G), SAT1 expression is particularly prominent in some 
scattered neurons with large cell bodies, resembling Golgi interneurons (I), while 
the granule cells (g) are faintly immunolabeled (inset). Purkinje cells are also 
immunostained by the affi nity-purifi ed antibodies against SAT1 (arrows; lower 
inset). The cerebellar nuclei (Cbn) contain scattered cells strongly immunostained 
for SAT1. Hardly any stained cells are detected in the white matter (W). 
Designations: *, canalis centralis; 7n, facial nucleus; Cb, cerebellum; Cbn, 
cerebellar nucleus (nucleus interpositus); cc, corpus callosum; CPu, caudate 
putamen; Cx, cortex; DCn, dorsal cochlear nucleus; Fr, frontal cortex; G, granule 
cell layer; g, granule cell; Gm, grey matter; GP, globus pallidus; Hc, hippocampus; I, 
interneuron; IC, inferior colliculus; lo, lateral olfactory tract; LL, lateral lemniscus 
nucleus; LSO, lateral superior olive; LV, lateral ventricle; M, molecular layer; P, 
Purkinje cell layer; Pir, piriform cortex; Pn, pontine nuclei; PnO, pontine reticular 
nucleus, oral part; Pu, Purkinje cell; Rt, reticular thalamic nucleus; SC, superior 
colluculus; SN, substantia nigra; Th, thalamus; Tu, olfactory tubercule; VPL, ventral 
posterolateral thalamic nucleus; W, white matter; ZI, zona incerta. Scale bars: 
20 µm (insets I), 40 µm (G, insets E and F), 100 µm (C–F,H,I), 350 µm (A).
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These pallidal neurons show strong colocalization of SAT1, PARV 
and GAD in GAD67gfp+ mice (Figure 6B). In the substantia nigra, 
SAT1 immunoreactivity occurs in both its compact and reticu-
late parts. Cell body staining of GABAergic reticulate neurons 
(Figure 3C) (Ribak et al., 1976) resembles SAT1 immunostaining 
of cell bodies in the globus pallidus (Figures 3A,B) and colocalize 
with GAD67gfp+ (Figure 6D). In contrast, the immunostaining is 
diffuse in the compact part, which primarily harbors dopaminergic 
neurons projecting to the striatum (Figure 3C) (Tepper and Lee, 
2007). The cell bodies of dopaminergic neurons are moderately 
SAT1 immunoreactive. Their target, the caudatoputamen,  receives 
in addition massive glutamatergic inputs from the cortex but itself 
does not contain glutamatergic or dopaminergic neuronal cell 
bodies. Instead, the caudatoputamen harbors two subpopulations 
of interneurons: cholinergic large-sized and GABAergic medium-
sized cells (Satoh et al., 1983; Ottersen and Storm-Mathisen, 1984). 
SAT1 antibodies label large-sized neurons weakly, while dispersed 
medium-sized neurons show strong labeling (Figure 3A; arrows). 
High power microscopy demonstrates that, similar to that in the 
pallidal neurons (Figure 3B), SAT1 immunoreactivity is enriched in 
medium-sized neurons’ long processes (Figure 3D; arrows). Thus, 
our data suggest that SAT1 expression is pronounced in GABAergic 
neurons and that it is distributed in the cell bodies and dendritic 
processes. In addition to recruitment to the plasma membrane, 
we also observed some SAT1 immunolabeling accumulating in 
the perinuclear region (e.g. in Figures 3B,D), which we judge as 
SAT1 in the trans-Golgi network (Bock et al., 1997) provided that 
syntaxin-6 colocalizes with SAT1 in transiently transfected PC12 
cells (Figure 1E).
PROMINENT SAT1 EXPRESSION IN NEOCORTICAL AND HIPPOCAMPAL 
INTERNEURONS
In the neocortex, prominent SAT1 expression is detected in small 
non-pyramidal cells scattered throughout all layers and resembling 
interneurons (Figures 4A,B, arrows). The pyramidal-like cells are 
weakly immunostained (Figure 4B; arrow heads), and contribute 
to the band-like staining of layer III and IV (Figure 4A).
In the hippocampus (Figure 5A), strong immunostaining for 
SAT1 is found in scattered cells both in cornu ammonis CA1-3 and 
in the dentate gyrus, while principal neurons are barely immuno-
labeled. The pattern of neuropil staining for SAT1, in particular in 
the lacunosum-moleculare resembles neuropil immunostaining 
seen for GABA (Ottersen and Storm-Mathisen, 1984) or GAD 
(Mugnaini and Oertel, 1985) in a meshwork of fi bers and respective 
terminal populations. The hippocampal immunostaining pattern 
is abolished upon pre-incubation of the antibodies with a GST 
fusion protein containing a peptide corresponding to the SAT1 
N-terminal (Figure 5B) thus strengthening the notion that the labe-
ling pattern we observe is genuine. Prominent immunoreactivity 
is seen in a subpopulation of interneuron-like cells in all layers, 
including stratum pyramidale (Figure 5C). Scattered interneuron-
like cells with pronounced staining in their cell bodies as well as 
their processes are also detected in other layers, such as stratum 
oriens (Figure 5D).
Likewise, the granule cells of the dentate gyrus show very low 
SAT1 immunoreactivity (Figures 5E,F). However, scattered cells 
strongly immunostained for SAT1 are located in the hilus and 
in the basal part of the granule cell layer. These neuron-like cells 
project their strongly stained processes amongst weakly stained 
granule cells (Figure 5F). These data are in accordance with 
reports that cell bodies of many major interneuron subpopula-
tions are located at the granule cell layer and hilus junction from 
FIGURE 3 | Basal ganglionic neurons exhibit strong SAT1 
immunoreactivity in their cell bodies as well as their processes. 
(A) Globus pallidus (GP) is highly enriched with SAT1 immunoreactive 
neurons. Smaller, scattered neuron-like cells strongly immunostained for SAT1 
are also detected in the caudatoputamen (CPu) (arrows). (B) High power light 
microscopy of neurons in the globus pallidus demonstrates SAT1 
immunostaining in the cell bodies as well as in their processes. Note that the 
immunostaining is restricted to the plasma membrane (arrow). (C) In the 
reticular part of substantia nigra (SNR), neuronal cell bodies and their 
processes are strongly immunolabeled for SAT1. The compact part of the 
substantia nigra (SNC) shows SAT1 immunostaining diffusely in the neuropil 
and in some smaller cell bodies. (D) A neuron-like cell is stained for SAT1 in 
the caudatoputamen. Note that the staining appears in the cell body and its 
processes (arrows). CPu, caudatoputamen; GP, globus pallidus; SNC, 
substantia nigra pars compacta; SNR, substantia nigra pars reticulata. Scale 
bars: 20 µm (B,D), 80 µm (A,C).
FIGURE 4 | Differential SAT1 immunoreactivity among cortical neuronal 
subpopulations. (A) SAT1 immunoreactive cells are detected in all layers of 
the neocortex. Layers III and V stand out as broad bands diffusely stained in 
the neuropil. (B) In the layer V, strong immunostaining for SAT1 is detected in 
scattered small neuron-like cells (arrows) while larger pyramidal-like cells 
(arrow heads) are moderately or weakly immunolabeled. I–VI: layers 1–VI. 
Scale bars: 100 µm (B), 200 µm (A).
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where their axon ascend amongst granule cell bodies to arborize 
in the molecular layer (Hálasy and Somogyi, 1993), bolstering 
the additional SAT1 targeting in axonal segments. Indeed, SAT1 
decorates processes immunostained for synaptophysin, a marker 
for synaptic vesicles, in differentiated PC12 cells transfected with 
SAT1 (Figure 1D).
In the neocortex and hippocampus SAT1 immunoreacti-
vity colocalizes with immunostaining for PARV and GAD67 
(Figure 6A). SAT1 staining also occurs in a subpopulation of 
GAD67gfp+ not immunostained for PARV supporting a role for 
SAT1 in a more diverse contingent of interneurons. Finally, SAT1 
expression was investigated in cultured neocortical fast-spiking 
(FS-like) GABAergic interneurons. Both cell bodies and processes, 
including putative dendrites and axons, exhibited SAT1 immuno-
reactivity and axonal SAT1 immunoreactivity colocalized with the 
vesicular GABA transporter VGAT in axonal varocosities (Figures 
6E,F). Thus, SAT1 expression is pronounced in PARV+ GABAergic 
interneurons both in vivo and in vitro, although it is not limited to 
this subclass of interneurons.
DISCUSSION
Functional characteristics of SAT1 are compatible with system 
A activity biochemically characterized several decades ago 
(Oxender and Christensen, 1963), including its affi nity for glu-
tamine and α-methylamino-iso-butyric acid (MeAIB) as well as 
its sensitivity to H+ (Sugawara et al., 2000; Varoqui et al., 2000; 
Chaudhry et al., 2002a). In contrast to the ubiquitous expression 
of SAT2, SAT1 mRNA transcript is preferentially enriched in 
FIGURE 5 | SAT1 immunostaining is enriched in hippocampal 
interneurons. (A) The hippocampal formation contains dispersed cells strongly 
immunostained for SAT1 while the principal cells are weakly immunostained. 
The neuropil is moderately stained in the vicinity of the principal cells (P and G) 
and in stratum lacunosum-moleculare (LM). (B) SAT1 immunostaining is 
abolished on preincubation of SAT1 antibody with the fusion protein used for 
immunization. (C) High power light microscopy confi rms strong SAT1 
immunostaining of non-pyramidal cells and their processes between faintly 
labeled pyramidal cells of CA1. Intracellular stained structures are visible. 
(D) Two SAT1 immunostained cells in the stratum oriens of CA1. Note that SAT1 
immunoreactivity extends to the distal parts of their processes. (E) The dentate 
area also possesses scattered cells strongly stained for SAT1. Note their 
prominently SAT1 stained processes. (F) A SAT1 immunostained neuron with 
its cell body located in the basal part of the granule cell layer. Note that it 
extends a immunostained process vertically between unstained granule cells 
(g) and a horizontal process along the inner border of the granule cell layer 
(arrow). G, granule cell layer; g, granule cell; H, hilus; LM, stratum lacunosum-
moleculare; M, stratum molecular of the area dentata; O, stratum oriens; P, 
stratum pyramidale; p, pyramidal cell; R, stratum radiatum. Scale bars: 20 µm 
(C, D, F), 75 µm (E), 150 µm (A,B).
Frontiers in Neuroanatomy www.frontiersin.org February 2010 | Volume 4 | Article 1 | 9
Solbu et al. SAT1 in GABAergic neurons
the brain, heart and placenta (Varoqui et al., 2000; Wang et al., 
2000; Chaudhry et al., 2002b), suggesting isoform-specifi c fun-
ctional roles of these transporters. We now reveal prominent 
SAT1 immunostaining in GABAergic neurons in many brain 
regions. SAT1 immunostaining extends into neuronal processes 
including axonal segments. SAT1 is not restricted to the pla-
sma membrane but also appears concentrated in intracellular 
organelles colocalized with syntaxin-6. Thus, our data suggest 
highly regulated expression of SAT1 underpinning specialized 
cell type-specifi c functions.
DIFFERENTIAL LOCALIZATION OF SAT1 AND SAT2 SUGGESTS ISOFORM-
SPECIFIC FUNCTIONAL ROLES
Our present fi ndings on the distribution of SAT1 confi rm pre-
vious in situ hybridization data suggesting that mRNA for SAT1 
is enriched in GABAergic neurons while mRNA for SAT2 is more 
abundant in glutamatergic neurons (Chaudhry et al., 2002b). 
Indeed, SAT1  immunoreactivity correlates well with the tissue GABA 
concentration such that the highest staining intensities for SAT1 
are found in globus pallidus and substantia nigra pars reticulata, 
the brain regions with the highest GABA content (Fahn and Cote, 
FIGURE 6 | SAT1 immunostaining is pronounced in GAD67/PARV+ neurons 
and is targeted to VGAT containing axonal segments. Young adult mice 
heterozygously expressing green fl uorescence protein (GFP) knocked into the 
GAD67 locus were perfusion fi xed and immunofl uorescently labeled for SAT1 
and cellular markers. (A) In the neocortex (L2/3) and hippocampus, SAT1 
immunoreactivity accumulates in the somatodendritic domains of a subset of 
GABAergic interneurons also containing PARV (arrows). Arrowheads indicate 
SAT1/GAD67gfp/+-positive GABAergic interneurons that fall into other subclasses 
of interneurons. (B) Co-localization of SAT1 and PARV immunoreactivities in the 
basal ganglia. Tripled labelled neurons and their processes appear in white/light 
pink color. Note that virtually all PARV-containing neurons in the globus pallidus 
(GP) and reticular thalamic nucleus (RTN) express SAT1. Open rectangle 
indicates the location of images in the majority of GABAergic neurons in RTN 
(C). (C) Channel separation reveals co-localization of SAT1 and PARV 
immunoreactivities in RTN. Arrows point to select triple-labelled cells. (D) SAT1 
immunoreactive GABAergic neurons lacking PARV immunoreactivity in the 
substantia nigra pars reticulata. (E,F) Hippocampal PARV+ interneurons were 
isolated and cultured for 12 days in vitro. Considerable SAT1 immunoreactivity 
was only found in cells co-expressing perineuronal net components (as revealed 
by Wisteria fl oribunda lectin binding), and the vesicular GABA transporter 
(VGAT). Arrows point to triple-labelled varicose axonal structures. Abbreviations: 
CPu, caudate putamen; GP, globus pallidus; or, stratum oriens; pyr, stratum 
pyramidale; rad, stratum radiatum; RTN, reticular thalamic nucleus. Scale 
bars = 4 µm (F), 14 µm (E), 30 µm (A,C,D), 100 µm (B).
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1968; Okada et al., 1971; Mugnaini and Oertel, 1985). Interestingly, 
the same brain regions are devoid of immunostaining for SAT2 
(Jenstad et al., 2009). At the cellular level, SAT1  immunostaining 
is more prominent in GABAergic neurons while SAT2 is expressed 
complementary to this transporter and restricted to glutamatergic 
neurons: in the cerebellum, SAT1 immunolabeling is enriched in 
inhibitory Golgi and Purkinje neurons, while SAT2 is selectively 
enriched in the glutamatergic unipolar brush cells (Jenstad et al., 
2009). In the neocortex and hippocampus, scattered GABAergic 
interneurons have high levels of SAT1 expression, while adjacent 
pyramidal neurons lack appreciable immunoreactivity. SAT2 exhi-
bits an opposite cellular expression pattern in the  cortex: it is barely 
detected in interneurons, while pyramidal neurons and hilar mossy 
cells, all having glutamatergic phenotypes, are SAT2 positive (Jenstad 
et al., 2009). In the caudatoputamen, we found strongly SAT1 
immunostained medium-sized neurons surrounded by large-sized 
neurons with barely detectable labeling for this protein. The latter 
group mediate cholinergic transmission, while the former subpo-
pulation of medium spiny neurons have previously been shown to 
have GABAergic phenotype and are not  immunostained for SAT2 
(Satoh et al., 1983; Ottersen and Storm-Mathisen, 1984; Jenstad 
et al., 2009). Thus, although weak immunostaining for SAT1 and 
its functional expression has been demonstrated in select neuronal 
populations also expressing SAT2 (Blot et al., 2009; Jenstad et al., 
2009), SAT1 and SAT2 – in general – show surprisingly conserved 
complementary expression patterns in the rodent forebrain.
Our data are thus in contrast to previous studies that failed to show 
preferential immustaining for SAT1 in inhibitory neurons (Varoqui 
et al., 2000; Mackenzie et al., 2003; Weiss et al., 2003; Melone et al., 
2004). In general, it has been concluded that SAT1 and SAT2 mediate 
the transport of amino acids for metabolic purposes (Rae et al., 2003; 
Conti and Melone, 2006). However, this does not exclude their roles 
in neurotransmitter regeneration. Indeed, SAT2 is preferentially enri-
ched in a subpopulation of glutamatergic neurons and it has been 
demonstrated that SAT2-mediated glutamine transport is intrinsic to 
sustain specifi c forms of retrograde signaling (Jenstad et al., 2009).
SAT1 expression does not discriminate between short- and 
long-axon GABAergic neurons and also appears in cytoplasmic 
organelles of both, e.g., striatal and pallidal GABAergic projec-
tion neurons and cortical and hippocampal interneurons. Staining 
of cytoplasmic organelles was also evident in SAT1-expressing 
neuronally- transformed PC12 cells in which SAT1 colocalized 
with syntaxin-6. Similarly, homologous SAT2 has been shown in 
the trans-Golgi network from where it is recruited to the plasma 
membrane by insulin (Hatanaka et al., 2006). Adaptive regulation 
is a hallmark of System A and N transport activities (Collarini and 
Oxender, 1987; Palacin et al., 1998), and regulation occurs at gene, 
mRNA and/or protein levels (Chaudhry et al., 2001, 2002b; Hyde 
et al., 2002; Palii et al., 2004; Solbu et al., 2005; Grewal et al., 2009). 
Indeed, brain-derived neurotrophic factor specially upregulates SAT1 
protein and increases glutamine uptake (Burkhalter et al., 2007).
SAT1 is not restricted to the cell bodies but is also targeted 
to axonal segments of GABAergic neurons: SAT1 is colocalized 
with VGAT in axonal varicosities in cultured PARV+ hippocampal 
interneurons. In the intact brain, neuropil staining pattern, e.g. in 
the lacunosum-molecular layer of the hippocampus, suggests the 
association of SAT1 with GABAergic axonal plexuses. The strong 
and dense immunolabeling of e.g. pontine nucleus consents with 
staining of the plexus of GABAergic processes in addition to cell 
bodies. Finally, in the dentate gyrus, SAT1 immunostained proces-
ses penetrate the granule cell layer as described for local interneuron 
axons (Hálasy and Somogyi, 1993). Our fi ndings thus concur with 
the demonstration of SAT1 being targeted to the axonal segments 
of cultured hippocampal neurons (Armano et al., 2002). In analogy, 
SAT2 is also observed on axonal segments, such as hippocampal 
mossy fi bers in CA3 (Jenstad et al., 2009). Collectively, our data 
suggest that SAT1 immunostaining is partially complementary to 
SAT2 and specifi cally enriched in subpopulations of GABAergic 
neurons, and that SAT1 expression is highly regulated.
SAT1 MAY PROVIDE GABAergic NEURONS WITH GLUTAMINE TO 
GENERATE GABA
Previous reports have shown that GABAergic nerve endings in 
cerebellar (Holten and Gundersen, 2008) or hippocampal (Storm-
Mathisen et al., 1986) slices can maintain GABA levels through a 
glutaminase reaction. This is also consistent with studies in primary 
cortical neuron cultures as well as in synaptosomes showing that 
addition of glutamine increases GABA formation by several folds 
(Ward et al., 1983; Yu et al., 1984; Battaglioli and Martin, 1990; 
Schousboe et al., 1993).
GABAergic neurons often exhibit higher prevailing fi ring fre-
quency (Freund and Buzsaki, 1996; Pan and McNaughton, 2004), 
and sustained synaptic transmission requires effi cient reple-
nishment of GABA transmitter pools. Nerve terminals concen-
trate GABA transporters (Ribak et al., 1996) to achieve suffi cient 
 reuptake of GABA that can be reused in synaptic transmission (Fan 
et al., 2006). There is also evidence that glutamine is not the only 
source of glutamate for GABA formation (Paulsen and Fonnum, 
1988; Patel et al., 2001). However, glutamine contributes substan-
tially to the vesicular pool of GABA as well as the  cytoplasmic pool 
(Waagepetersen et al., 2001). Accordingly, we fi nd strong immu-
nolabling for SAT1 both in the cell body and in the processes, and 
the staining pattern resembles GAD (Mugnaini and Oertel, 1985), 
suggesting that SAT1 provides a precursor to cell compartments 
capable of GABA synthesis. Finally, mice genetically inactivated for 
nerve terminal GABA uptake survive and maintain vesicular GABA 
content (Jensen et al., 2003) indicating that alternative mechani-
sms or precursors must exist to replenish GABA pools, including 
glia-derived glutamine. Our current data are well suited to support 
the concept of GABA-glutamine recycling through conversion to 
glutamine in glia followed by transport to neurons by the concer-
ted action of SN1/SN2 and SAT1. The data thus support previous 
demonstrations of glutamine being a preferred precursor for GABA 
synthesis (Reubi et al., 1978; Paulsen et al., 1988; Battaglioli and 
Martin, 1990; Martin and Rimvall, 1993; Sonnewald et al., 1993). 
As disruption of neuronal glutamine uptake by MeAIB reduces 
inhibitory synaptic transmission, System A mediated glutamine 
activity is important for dynamic sustainance of intracellular pool 
of GABA (Fricke et al., 2007). Moreover, selective enrichment of 
SAT1 in GABAergic neurons suggests that SAT1 may be the main 
transporter involved in glutamine uptake for GABA generation. 
However, recycling of GABA may not be restricted to SAT1 or gluta-
mine. Additional transporters and/or alternative mechanisms may 
also exist to fi ne-tune this essential process. Although less effi ciently, 
Frontiers in Neuroanatomy www.frontiersin.org February 2010 | Volume 4 | Article 1 | 11
Solbu et al. SAT1 in GABAergic neurons
SAT1 can also transport several other neutral amino acids, inclu-
ding alanine, and thus may mediate transport of both glutamine 
and these amino acids for metabolic purposes.
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